US Stock MarketDetailed Quotes

VERV Verve Therapeutics

Watchlist
  • 6.010
  • -0.410-6.39%
Close Jan 8 16:00 ET
  • 5.912
  • -0.098-1.64%
Post 20:01 ET
508.83MMarket Cap-2.44P/E (TTM)

About Verve Therapeutics Company

Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases. The company was founded by Burt A. Adelman, Keith J. Joung, Sekar Kathiresan, Kiran Musunuru, Anthony Philippakis, Issi Rozen, and Barry Ticho in 2018 and is headquartered in Boston, MA.

Company Profile

SymbolVERV
Company NameVerve Therapeutics
Listing DateJun 17, 2021
Issue Price19.00
Founded2018
CEODr. Sekar Kathiresan, M.D.
MarketNASDAQ
Employees255
Fiscal Year Ends12-31
Address201 Brookline Avenue,Suite 601
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02215
Phone1-617-603-0070

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Sekar Kathiresan, M.D.
  • Chief Executive Officer and Director
  • 9.32M
  • Andrew D. Ashe, J.D.
  • President and Chief Operating Officer
  • --
  • Joan Nickerson
  • Chief Administrative Officer
  • --
  • Frederick Fiedorek, M.D.
  • Chief Medical Officer
  • --
  • Dr. Ourania Tatsis, PhD
  • Director; Executive Vice President and Chief Regulatory and Quality Officer of Vertex Pharmaceuticals
  • --
  • Troy Lister, PhD
  • Chief Scientific Officer
  • --
  • Allison Dorval
  • Chief Financial Officer and Principal Accounting Officer
  • 3.48M
  • Dr. Burt A. Adelman, M.D.
  • Chairman of the Board
  • 451.88K
  • Alexander G. Cumbo
  • Independent Director
  • 405.88K
  • Michael F. Maclean
  • Independent Director
  • 521.07K
  • Sheila Mikhail, J.D.
  • Independent Director
  • 412.38K
  • Dr. Krishna Yeshwant, M.D.
  • Independent Director
  • 410.88K
  • Jodie P. Morrison
  • Independent Director
  • --
  • Lonnel Coats
  • Independent Director
  • 407.38K
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.